Cargando…
PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
SIMPLE SUMMARY: Colorectal cancer (CRC) is a very heterogeneous disease. Efforts to characterize and search for biomarkers for these patients are currently ongoing in the hope of establishing a more targeted therapeutic approach. The role of PD-1 ligand (PD-L1) expression as a biomarker has not yet...
Autores principales: | Azcue, Pablo, Encío, Ignacio, Guerrero Setas, David, Suarez Alecha, Javier, Galbete, Arkaitz, Mercado, María, Vera, Ruth, Gomez-Dorronsoro, Maria Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073668/ https://www.ncbi.nlm.nih.gov/pubmed/33920689 http://dx.doi.org/10.3390/cancers13081943 |
Ejemplares similares
-
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma
por: Azcue, Pablo, et al.
Publicado: (2021) -
Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017) -
Subtype classification of malignant lymphoma using immunohistochemical staining pattern
por: Hashimoto, Noriaki, et al.
Publicado: (2022) -
Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
por: Goutas, Dimitrios, et al.
Publicado: (2022) -
Infección y trombosis asociada a la COVID-19: posible papel del grupo sanguíneo ABO
por: Zalba Marcos, Saioa, et al.
Publicado: (2020)